Routine mammograms are a critical tool for breast cancer screening. However, they may also hold crucial, potentially untapped ...

Cantor Fitzgerald analyst Olivia Brayer initiated coverage of Inhibikase Therapeutics (IKT) with an Overweight rating and $4 price target ...

The FDA approved a Phase 2b trial of CS1, a new PAH therapy being tested for its impact on lung vessel resistance and ...

Idiopathic pulmonary fibrosis (IPF) is a chronic disease in which healthy lung tissue is gradually replaced by scar tissue.

When Amy was first diagnosed with scleroderma, she never imagined it would lead to a lifelong journey with lung disease.

Pulmonary hypertension (PH) is a rare group of serious but LOCALIZED medical conditions that can have full-body impacts if ...

Existing risk assessment strategies for predicting mortality in PAH may be improved by the addition of GDF-15 as a biomarker.

Despite affecting approximately 1% of the population and carrying significant mortality risk, pulmonary hypertension (PH) remains underrecognized compared to other cardiovascular conditions. Several ...

Pulmonary hypertension (PH) is on the rise and doubled in prevalence in Western countries over the past decade. PH is associated with high morbidity and ...

Pulmonary hypertension (PH) because of chronic lung disease is categorized as Group 3 PH in the most recent classification system. Prevalence of these diseases is increasing over time, creating a ...

Five years ago, Eric Borstein was rushed to the hospital after he collapsed in the bedroom of his California home. It was then that his seemingly healthy life had taken an unexpected turn. With the ...